Guardant Health Correlations
GH Stock | USD 44.72 1.52 3.29% |
The current 90-days correlation between Guardant Health and Twist Bioscience Corp is 0.58 (i.e., Very weak diversification). The correlation of Guardant Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Guardant Health Correlation With Market
Weak diversification
The correlation between Guardant Health and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Guardant Health and DJI in the same portfolio, assuming nothing else is changed.
Guardant |
Moving together with Guardant Stock
0.72 | ALC | Alcon AG | PairCorr |
0.89 | BSX | Boston Scientific Corp | PairCorr |
0.69 | CVS | CVS Health Corp Aggressive Push | PairCorr |
0.62 | EHC | Encompass Health Corp | PairCorr |
0.77 | FNA | Paragon 28 | PairCorr |
0.77 | MDT | Medtronic PLC | PairCorr |
0.79 | SYK | Stryker | PairCorr |
0.68 | GDRX | Goodrx Holdings | PairCorr |
0.87 | IRTC | iRhythm Technologies | PairCorr |
0.72 | NPCE | Neuropace | PairCorr |
0.74 | NVRO | Nevro Corp | PairCorr |
0.85 | NYXH | Nyxoah | PairCorr |
0.78 | OPCH | Option Care Health | PairCorr |
Moving against Guardant Stock
0.32 | EW | Edwards Lifesciences Corp | PairCorr |
0.67 | SGHT | Sight Sciences | PairCorr |
0.51 | SRDX | SurModics | PairCorr |
0.42 | MODD | Modular Medical | PairCorr |
0.41 | MDAI | Spectral AI | PairCorr |
0.41 | APYX | Apyx Medical | PairCorr |
0.4 | RXST | Rxsight | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Guardant Stock performing well and Guardant Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Guardant Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ILMN | 1.90 | (0.75) | 0.00 | (0.95) | 0.00 | 2.87 | 15.07 | |||
TWST | 3.10 | (0.04) | 0.00 | (0.10) | 0.00 | 6.39 | 18.27 | |||
NTRA | 2.16 | (0.03) | 0.00 | (0.10) | 0.00 | 4.36 | 13.77 | |||
CDNA | 3.06 | (0.12) | 0.00 | (0.13) | 0.00 | 5.88 | 19.59 | |||
MYGN | 2.53 | (0.47) | 0.00 | (0.76) | 0.00 | 4.14 | 26.72 | |||
CSTL | 2.47 | (0.47) | 0.00 | (2.04) | 0.00 | 4.51 | 23.81 | |||
PSNL | 5.65 | 0.54 | 0.06 | 0.07 | 5.62 | 9.82 | 61.04 | |||
A | 1.14 | (0.14) | 0.00 | (0.23) | 0.00 | 2.92 | 9.03 | |||
TMO | 1.12 | 0.00 | 0.00 | (0.07) | 0.00 | 2.40 | 10.04 |
Guardant Health Corporate Management
Jennifer Higgins | Senior Affairs | Profile | |
Stephen Murphy | Senior Marketing | Profile | |
John Saia | Chief Secretary | Profile | |
Christopher Freeman | Chief Officer | Profile | |
John JD | Chief Secretary | Profile | |
Zarak Khurshid | Vice Relations | Profile |